Print

Lay Description

Are you undergoing treatment for a blood cancer diagnosis and experiencing poor sleep?


Researchers at the Mays Cancer Center are seeking US-based adults diagnosed with blood cancer and experiencing sleep disturbance to participate in a 20-week remote study testing a digital wellness intervention. Participants in this study will be assigned to use one of two digital wellness apps 10 minutes per day over 8-weeks to determine if it can help improve sleep, immune function, and other psychological and emotional outcomes.


This study is completely remote (there are no in-person visits with the research team) and patients from across the USA are invited.


Participation involves:

  • One brief 30-minute virtual meeting with a research assistant
  • Completing online surveys
  • Providing three blood samples over the 20-week study at a lab close to you
  • Tracking sleep using a small device and daily diary
  • Using a wellness app for 10 minutes per day for 8-weeks


Participants who qualify and are enrolled in the study will be compensated at regular intervals, up to $100 total.

Category

  • Cancers and Other Neoplasms
  • Acute Lymphoblasic Leukemia
  • Acute Myeloid Leukemia
  • Hematological Malignancy
  • Leukemia, other
  • Lymphoid Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Myeloid and Monocytic Leukemia
  • Myeloma
  • Other Hematopoietic
IRB Number
20220567HU
NCT Number
ct.gov registration not required
Open to Enrollment
Yes

Eligibility

Eligible Ages
18
Eligible Genders
All
Accepts Healthy Volunteers

Inclusion Criteria

You may qualify for the study if you:

  • Are over 18 and reside in the USA
  • Have a blood cancer diagnosis and are currently receiving treatment
  • Experience sleep disturbance, such as difficulty falling asleep, staying asleep, or poor quality of sleep
  • Own a smartphone

Are willing to complete the study procedures

Exclusion Criteria

Other Exclusion Criteria:

  • Not residing in the USA
  • Non-English speaking
  • Not in active treatment or not on stable treatment
  • Diagnosed or at high risk for sleep apnea

Regular use of sleep aids on 3 or more nights per week

Study Design

Arm Groups

Study Contact


Frances Crawford
(210) 450-5037
crawfordf1@uthscsa.edu

Sonia Creighton
(210) 450-1366
creighton@uthscsa.edu

Myrna Montenegro
(210) 450-5954
montenegro@uthscsa.edu

Courtney Nichols
(210) 450-1794
nicholsc2@uthscsa.edu

Mailbox Ctrc Regulatory Affairs
regaffapp@uthscsa.edu

Kathleen Rodriguez
(210) 450-1365
rodriguezk3@uthscsa.edu

Benjamin Schleif
(210) 450-1366
schleifb@uthscsa.edu

Morgan Seekatz
(210) 450-1133
seekatz@uthscsa.edu

Jillian Johnson
+1 (814) 424-5601
johnsonj27@uthscsa.edu

Principal Investigator
Jennifer Huberty